(0.09%) 5 251.00 points
(0.00%) 39 643 points
(0.20%) 18 292 points
(-0.37%) $77.97
(-0.49%) $2.24
(-0.70%) $2 358.40
(-0.97%) $28.23
(-0.26%) $1 004.60
(-0.01%) $0.928
(0.17%) $10.85
(-0.05%) $0.798
(-0.51%) $92.20
Live Chart Being Loaded With Signals
TScan Therapeutics, Inc., a preclinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell therapies for the treatment of patients with cancer...
Stats | |
---|---|
Today's Volume | 114 185 |
Average Volume | 209 604 |
Market Cap | 337.07M |
EPS | $0 ( 2024-05-08 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -5.73 |
ATR14 | $0.0200 (0.26%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-01 | Louis Chrystal | Buy | 380 000 | Stock Option (Right to Buy) |
2024-04-22 | Louis Chrystal | Buy | 0 | |
2024-04-19 | Baker Bros. Advisors Lp | Buy | 8 851 451 | Warrants to purchase Common Stock |
2024-04-19 | Baker Bros. Advisors Lp | Buy | 825 968 | Warrants to purchase Common Stock |
2024-04-19 | Lynx1 Capital Management Lp | Buy | 5 000 000 | Pre-funded Warrant (right to buy) |
INSIDER POWER |
---|
99.18 |
Last 92 transactions |
Buy: 66 852 110 | Sell: 5 443 695 |
Volume Correlation
TScan Therapeutics, Inc. Correlation
10 Most Positive Correlations | |
---|---|
CRTO | 0.899 |
EBSB | 0.886 |
VSEC | 0.884 |
ADSE | 0.882 |
COOP | 0.882 |
QNST | 0.88 |
TXRH | 0.878 |
SKYW | 0.876 |
AAON | 0.876 |
EVER | 0.875 |
10 Most Negative Correlations | |
---|---|
LTRX | -0.906 |
HFFG | -0.889 |
ATNX | -0.881 |
SLVO | -0.879 |
BRQS | -0.878 |
TRIT | -0.875 |
CNTG | -0.873 |
CYAN | -0.872 |
CUE | -0.87 |
VORB | -0.867 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
TScan Therapeutics, Inc. Correlation - Currency/Commodity
TScan Therapeutics, Inc. Financials
Annual | 2023 |
Revenue: | $21.05M |
Gross Profit: | $15.69M (74.53 %) |
EPS: | $-1.360 |
FY | 2023 |
Revenue: | $21.05M |
Gross Profit: | $15.69M (74.53 %) |
EPS: | $-1.360 |
FY | 2022 |
Revenue: | $13.54M |
Gross Profit: | $8.40M (62.05 %) |
EPS: | $-2.74 |
FY | 2021 |
Revenue: | $10.14M |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-4.17 |
Financial Reports:
No articles found.
TScan Therapeutics, Inc.
TScan Therapeutics, Inc., a preclinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell therapies for the treatment of patients with cancer. It is developing TSC-100 and TSC-101 for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation; and TSC-200, TSC-201, TSC-202, TSC-203, and TSC-204 for the treatment of solid tumors. The company is also developing vaccines for infectious diseases, such as SARS-CoV-2. It has a collaboration and license agreement with Novartis Institutes for BioMedical Research, Inc., to identify novel cancer antigens from the T cells of patients with a certain specific type of cancer. TScan Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators